Product Code: SR112023A6256
Abstract
Market Overview:
The global vascular grafts market size reached US$ 1.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028.
Vascular grafts are medical devices mainly used in vascular bypass procedures to direct the blood flow from one area of the body to another by reconnecting the blood vessels. They are manufactured using polyurethane (PU), biosynthetic, polyester, and polytetrafluoroethylene (PTFE) materials. Vascular grafts are commonly employed to replace injured veins, arteries, blood vessels, and valves during organ transplantation or hemodialysis. Other instances wherein medical practitioners require vascular grafts include vascular occlusion, aneurysms, kidney failure, and coronary artery diseases. They help reduce blood leakage and allow good cell invasion from the adventitia without affecting the endothelialization rate. Hemodialysis access, coronary artery, endovascular stent, and peripheral vascular are some common product types.
Vascular Grafts Market Trends:
The increasing incidences of chronic heart diseases and the growing demand for minimally invasive (MI) procedures are creating a positive outlook for the market. Vascular grafts are widely used in bypass surgeries to diagnose and treat angina pectoris, heart attack, heart artery blockages, and other cardiovascular diseases (CVDs). The widespread product adoption can also be attributed to the rising prevalence of high blood pressure and cholesterol levels due to sedentary lifestyles and the steadily growing geriatric population. Apart from this, the development of three-dimensional (3D) printed polymeric vascular grafts that are biodegradable, mechanically compatible with vascular tissues, and support neo-tissue formation and growth are providing an impetus to the market growth. Furthermore, the extensive utilization of prosthetic grafts, such as electrospun PU vascular grafts for complex vascular trauma that reduce the risk of neointimal formation, is positively influencing the market growth. Other factors, including the significant growth in the healthcare industry, extensive research and development (R&D) activities, and rapid technological advancements in next-generation tissue-engineered vascular grafts, are supporting the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global vascular grafts market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, raw material, application and end user.
Breakup by Product:
Endovascular Stent Grafts
Hemodialysis Access Grafts
Coronary Artery By-Pass Grafts
Vascular Grafts for Aorta Disease
Peripheral Vascular Grafts
Breakup by Raw Material:
Polytetrafluoroethylene (PTFE)
Polyester
Polyurethane
Biosynthetic
Breakup by Application:
Cardiac Aneurysm
Kidney Failure
Vascular Occlusion
Coronary Artery Disease
Breakup by End User:
Hospitals
Ambulatory Surgical Centers (ASCs)
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, B. Braun SE (B. Braun Holding GmbH & Co. KG), Becton, Dickinson and Company, Cook Group Incorporated, Cordis, CryoLife Inc., Getinge AB, Heat Medical Europe BV, LeMaitre Vascular, Medtronic plc, Terumo Corporation and W. L. Gore & Associates Inc.
Key Questions Answered in This Report:
- How has the global vascular grafts market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global vascular grafts market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the raw material?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global vascular grafts market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Vascular Grafts Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Endovascular Stent Grafts
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Hemodialysis Access Grafts
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Coronary Artery By-Pass Grafts
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Vascular Grafts for Aorta Disease
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Peripheral Vascular Grafts
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
7 Market Breakup by Raw Material
- 7.1 Polytetrafluoroethylene (PTFE)
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Polyester
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Polyurethane
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Biosynthetic
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by Application
- 8.1 Cardiac Aneurysm
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Kidney Failure
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Vascular Occlusion
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Coronary Artery Disease
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by End User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Ambulatory Surgical Centers (ASCs)
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.1.4 SWOT Analysis
- 15.3.2 B. Braun SE (B. Braun Holding GmbH & Co. KG)
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.3 Becton, Dickinson and Company
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.3.3 Financials
- 15.3.3.4 SWOT Analysis
- 15.3.4 Cook Group Incorporated
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.5 Cordis
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.6 CryoLife Inc.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.7 Getinge AB
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Heat Medical Europe BV
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.9 LeMaitre Vascular
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.10 Medtronic plc
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.11 Terumo Corporation
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.12 W. L. Gore & Associates Inc.
- 15.3.12.1 Company Overview
- 15.3.12.2 Product Portfolio